In other words: your birthstone. Though typically ... which complements Cancer’s need for security and comfort.” Leo: Ruby (July), Peridot (August), Sardonyx (August), Spinel (August ...

GSK has said that a regimen of PD-1 inhibitor Jemperli with PARP inhibitor Zejula has shown efficacy in the second stage of the RUBY trial, which could open up wider use in endometrial cancer.